|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_ForwardLookingEvaluationsAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
26.02.2025
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
In accordance with Article 10 of Capital Markets Board's Communique on Material Events numbered II-15.1, our Guidance for Underlying Net Income in TFRS (Turkish Financial Reporting Standards), previously announced on February 26, 2025, has been revised from TL 5.0-6.0 billion to TL ~7.5 billion. Accordingly, our updated guidance is presented below.
Operational Earnings (EBITDA + Capex Reimbursements): TL 52-57 billion Underlying Net Income (Reported Net Profit w/o Exceptional İtems): TL ~7.5 billion Investments: TL 21-24 billion Regulatory Asset Base: TL 80-90 billion
Detailed information regarding this topic can be found in our Investor Presentation at the below link:
Kind regards. This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||